J Dermatolog Treat
-
Publication Venue For
- Rituximab and low dose oral immune modulating treatment to maintain a sustained response in severe pemphigus patients.. 30:340-345. 2019
- What is clearance worth? Patients' stated risk tolerance for psoriasis treatments.. 28:709-715. 2017
- Benefit-risk tradeoff preferences for chronic hand eczema treatments.. 28:40-46. 2017
- Should all patients undergoing treatment with biologic agents be screened annually for latent tuberculosis infection with an interferon gamma release assay?. 27:378-380. 2016
- Psoriasis patients' willingness to accept side-effect risks for improved treatment efficacy.. 26:507-513. 2015
- The value to patients of reducing lesion severity in plaque psoriasis.. 22:266-275. 2011